US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MetaVia Inc

0.7051

-0.0316-4.30%

Post-market: 0.70510.00000.00%19:58 EDT

Volume:58.51K

Turnover:40.99K

Market Cap:13.81M

PE:-0.26

High:0.7300

Open:0.7251

Low:0.6807

Close:0.7367

Loading ...

Overview Company News Filings

MetaVia doses first patient in 48 mg MAD cohort of its Phase 1 trial

Metavia Inc. Doses First Patient in 48 mg Cohort of Phase 1 Trial for Obesity Drug DA-1726, Top-Line Data Expected by End of 2025

Metavia Inc - Top-Line Data Expected in Q4 2025

THOMSON REUTERS

Metavia Doses First Patient in the 48 Mg Mad Cohort of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity to Further Explore Maximum Tolerated Dose

THOMSON REUTERS

Metavia Files Prospectus for Investors to Sell 14.1 Million Shares

MT Newswires Live

BRIEF-Metavia Files For Resale Of Up To 14.1 Million Shares Of Common Stock By Selling Securityholders

MetaVia files to sell 14.08M shares of common stock for holders

Metavia Inc Files for Resale of up to 14.1 Mln Shares of Common Stock by Selling Securityholders - SEC Filing

THOMSON REUTERS

Metavia Inc. Conducted Virtual Annual Stockholders Meeting

MetaVia announces presentation of pre-clinical data on DA-1241

Metavia Inc - Combination Therapy Decreases Inflammatory and Fibrotic Gene Expression

THOMSON REUTERS

Metavia Presents Pre-Clinical Data on Da-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the Ada's 85TH Scientific Session

THOMSON REUTERS

MetaVia Inc. Announces Promising Pre-Clinical Data on DA-1241 with Efruxifermin Combination for MASH Treatment at ADA's Scientific Session

Metavia Inc. CFO Marshall H. Woodworth Reports Acquisition of Common Shares

Metavia Inc. Faces Nasdaq Delisting Risk Due to Sub-$1 Stock Price

Metavia Inc. Unveils Presentation on Innovative Cardiometabolic Therapies Targeting Obesity and MASH

Dong-A ST Co., Ltd Acquires Common Shares of Metavia Inc

MetaVia Is Maintained at Buy by Maxim Group

MetaVia price target lowered to $3 from $6 at Maxim

Maxim Group Sticks to Its Buy Rating for MetaVia (MTVA)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MTVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","market":"US","secType":"STK","nameCN":"MetaVia Inc","latestPrice":0.70505,"timestamp":1753473600000,"preClose":0.7367,"halted":0,"volume":58512,"hourTrading":{"tag":"盘后","latestPrice":0.70505,"preClose":0.70505,"latestTime":"19:58 EDT","volume":84,"amount":59.7491,"timestamp":1753487907366},"delay":0,"floatShares":4610670,"shares":19589132,"eps":-2.717151,"marketStatus":"Market Closed","change":-0.03165,"latestTime":"07-25 16:00:00 EDT","open":0.72505,"high":0.73,"low":0.6807,"amount":40992.881121599996,"amplitude":0.06692,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.717151,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":7,"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":0.7367,"preHourTrading":{"tag":"盘前","latestPrice":0.7367,"preClose":0.7369,"latestTime":"09:13 EDT","volume":593,"amount":436.86310000000003,"timestamp":1753449222362},"postHourTrading":{"tag":"盘后","latestPrice":0.70505,"preClose":0.70505,"latestTime":"19:58 EDT","volume":84,"amount":59.7491,"timestamp":1753487907366},"volumeRatio":1.1167136225023864},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","floatShares":4610670,"roa":"-110.71%","roe":"-339.64%","lyrEps":-3.556986,"volumeRatio":1.1167136225023864,"shares":19589132,"dividePrice":0,"high":0.73,"amplitude":0.06692,"preClose":0.7367,"low":0.6807,"week52Low":0.6015,"pbRate":"3.15","week52High":4.363,"institutionHeld":0,"latestPrice":0.70505,"eps":-2.717151,"divideRate":0,"volume":58512,"delay":0,"ttmEps":-2.717151,"open":0.72505,"prevYearClose":2.03,"prevWeekClose":0.6739,"prevMonthClose":0.6432,"prevQuarterClose":0.6432,"fiveDayClose":0.6739,"twentyDayClose":0.68,"sixtyDayClose":0.7801},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550630738","title":"MetaVia doses first patient in 48 mg MAD cohort of its Phase 1 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2550630738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550630738?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:45","pubTimestamp":1752065157,"startTime":"0","endTime":"0","summary":"MetaVia (MTVA) announced dosing of the first patient in the 48 mg, multiple ascending dose, MAD, cohort of its Phase 1 clinical trial of DA-1726, a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metavia-doses-first-patient-in-48-mg-mad-cohort-of-its-phase-1-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metavia-doses-first-patient-in-48-mg-mad-cohort-of-its-phase-1-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2550563712","title":"Metavia Inc. Doses First Patient in 48 mg Cohort of Phase 1 Trial for Obesity Drug DA-1726, Top-Line Data Expected by End of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2550563712","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550563712?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:31","pubTimestamp":1752064291,"startTime":"0","endTime":"0","summary":"Metavia Inc. Doses First Patient in 48 mg Cohort of Phase 1 Trial for Obesity Drug DA-1726, Top-Line Data Expected by End of 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via PR Newswire  on July 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL3BNh1T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2550563760","title":"Metavia Inc - Top-Line Data Expected in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2550563760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550563760?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:31","pubTimestamp":1752064263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nTUA7NQNGZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2550376016","title":"Metavia Doses First Patient in the 48 Mg Mad Cohort of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity to Further Explore Maximum Tolerated Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2550376016","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550376016?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:31","pubTimestamp":1752064263,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nTUA7NQNGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2548843324","title":"Metavia Files Prospectus for Investors to Sell 14.1 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2548843324","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548843324?lang=en_us&edition=fundamental","pubTime":"2025-07-03 05:50","pubTimestamp":1751493029,"startTime":"0","endTime":"0","summary":"Metavia (MTVA) late Wednesday filed a registration statement for its shareholders to resell up to about 14.1 million shares from time to time.The shares resulted from a private placement in May, according to the filing. Metavia will not receive any proceeds from the resale.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTVA","ISBC","BK4139","BK4211"],"gpt_icon":0},{"id":"2548181778","title":"BRIEF-Metavia Files For Resale Of Up To 14.1 Million Shares Of Common Stock By Selling Securityholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2548181778","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548181778?lang=en_us&edition=fundamental","pubTime":"2025-07-03 04:11","pubTimestamp":1751487093,"startTime":"0","endTime":"0","summary":"BRIEF-Metavia Files For Resale Of Up To 14.1 Million Shares Of Common Stock By Selling SecurityholdersJuly 2 (Reuters) - MetaVia Inc MTVA.O:METAVIA INC FILES FOR RESALE OF UP TO 14.1 MILLION SHARES OF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nFWN3SZ0MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2548810335","title":"MetaVia files to sell 14.08M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2548810335","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548810335?lang=en_us&edition=fundamental","pubTime":"2025-07-03 04:10","pubTimestamp":1751487015,"startTime":"0","endTime":"0","summary":"16:08 EDT MetaVia (MTVA) files to sell 14.08M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metavia-files-to-sell-14-08m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metavia-files-to-sell-14-08m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2548174758","title":"Metavia Inc Files for Resale of up to 14.1 Mln Shares of Common Stock by Selling Securityholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2548174758","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548174758?lang=en_us&edition=fundamental","pubTime":"2025-07-03 04:07","pubTimestamp":1751486856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nFWN3SZ0MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2548170490","title":"Metavia Inc. Conducted Virtual Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2548170490","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548170490?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:06","pubTimestamp":1751313984,"startTime":"0","endTime":"0","summary":"Metavia Inc. held a virtual annual meeting of stockholders on June 30, 2025. During the meeting, stockholders voted to elect Mark A. Glickman and Michael Salsbury as Class III directors. The appointment of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, stockholders approved the issuance of shares of common stock in connection with a private placement to Dong-A Socio Holdings Co., Ltd. Furthermore, authorization was granted for one or more adjournments of the meeting to solicit additional proxies if needed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via EDGAR, the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL9n4v3F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2545455954","title":"MetaVia announces presentation of pre-clinical data on DA-1241","url":"https://stock-news.laohu8.com/highlight/detail?id=2545455954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545455954?lang=en_us&edition=fundamental","pubTime":"2025-06-23 04:55","pubTimestamp":1750625730,"startTime":"0","endTime":"0","summary":"MetaVia (MTVA) announced the presentation of pre-clinical data on DA-1241, a novel G-Protein-Coupled Receptor 119 agonist, demonstrating additive h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metavia-announces-presentation-of-pre-clinical-data-on-da-1241-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metavia-announces-presentation-of-pre-clinical-data-on-da-1241-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2545864544","title":"Metavia Inc - Combination Therapy Decreases Inflammatory and Fibrotic Gene Expression","url":"https://stock-news.laohu8.com/highlight/detail?id=2545864544","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545864544?lang=en_us&edition=fundamental","pubTime":"2025-06-21 21:00","pubTimestamp":1750510830,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250621:nFWN3SN04Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2545648645","title":"Metavia Presents Pre-Clinical Data on Da-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the Ada's 85TH Scientific Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2545648645","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545648645?lang=en_us&edition=fundamental","pubTime":"2025-06-21 21:00","pubTimestamp":1750510830,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250621:nFWN3SN04Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2545486451","title":"MetaVia Inc. Announces Promising Pre-Clinical Data on DA-1241 with Efruxifermin Combination for MASH Treatment at ADA's Scientific Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2545486451","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545486451?lang=en_us&edition=fundamental","pubTime":"2025-06-21 21:00","pubTimestamp":1750510819,"startTime":"0","endTime":"0","summary":"MetaVia Inc. Announces Promising Pre-Clinical Data on DA-1241 with Efruxifermin Combination for MASH Treatment at ADA's Scientific Session. Metavia Inc. announced new pre-clinical data on their novel drug, DA-1241, at the American Diabetes Association's 85th Scientific Sessions in Chicago, Illinois. The study highlights the additive hepatoprotective effects of DA-1241, a G-Protein-Coupled Receptor 119 agonist, when combined with Efruxifermin, a fibroblast growth factor 21 analogue, in a mouse model of metabolic dysfunction-associated steatohepatitis . The data, presented on June 22, 2025, by Yuna Chae, Lead Research Scientist at Dong-A ST Research Center, demonstrated synergistic benefits in reducing liver fat, inflammation, and fibrosis. These findings build upon previous Phase 2a clinical trial results and will be accessible on MetaVia's website and the journal Diabetes online.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. Wh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250621:nNDL9HFWGp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2541096607","title":"Metavia Inc. CFO Marshall H. Woodworth Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2541096607","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541096607?lang=en_us&edition=fundamental","pubTime":"2025-06-05 04:01","pubTimestamp":1749067306,"startTime":"0","endTime":"0","summary":"Marshall H. Woodworth, the Chief Financial Officer of Metavia Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9kDcxm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Metavia Inc. CFO Marshall H. Woodworth Reports Acquisition of Common Shares","news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2539038842","title":"Metavia Inc. Faces Nasdaq Delisting Risk Due to Sub-$1 Stock Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2539038842","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539038842?lang=en_us&edition=fundamental","pubTime":"2025-05-31 05:06","pubTimestamp":1748639204,"startTime":"0","endTime":"0","summary":"Metavia Inc. has announced that it received a notice from the Nasdaq Stock Market LLC on May 29, 2025, indicating that the company's common stock has not met the minimum bid price requirement for continued listing on the Nasdaq Capital Market. For the past 30 consecutive business days, Metavia's stock has closed below $1.00 per share, falling short of the requirement outlined in Nasdaq Marketplace Rule 5550. The company has until November 25, 2025, to regain compliance, either by achieving a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days or by other measures such as a reverse stock split. If compliance is not achieved, Metavia may pursue additional time but could face delisting from Nasdaq if the issue remains unresolved. The company is actively monitoring its stock price and exploring options to address the deficiency.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDLRnHTC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2537935332","title":"Metavia Inc. Unveils Presentation on Innovative Cardiometabolic Therapies Targeting Obesity and MASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2537935332","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537935332?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:08","pubTimestamp":1747832923,"startTime":"0","endTime":"0","summary":"MetaVia Inc., a clinical-stage biotech company focused on cardiometabolic diseases, recently presented updates on its pipeline of next-generation therapeutics targeting obesity and MASH. The company's investigational drug, DA-1726, a novel GLP1R/GCGR dual agonist, is currently in Phase 1 trials and has shown promising results with significant weight loss and reductions in fasted glucose levels. Additionally, DA-1241, targeting MASH, has met its Phase 2a primary endpoint, demonstrating direct hepatic effects and a strong safety profile. MetaVia continues to explore further studies and regulatory interactions for these treatments. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL2lLtmb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2537623689","title":"Dong-A ST Co., Ltd Acquires Common Shares of Metavia Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537623689","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537623689?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:17","pubTimestamp":1747772238,"startTime":"0","endTime":"0","summary":"Dong-A ST Co., Ltd, a beneficial owner, reported an acquisition of common shares of Metavia Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL8h4Ngl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2536406636","title":"MetaVia Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2536406636","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536406636?lang=en_us&edition=fundamental","pubTime":"2025-05-20 00:09","pubTimestamp":1747670940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MTVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 12:09 ET (16:09 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA"],"gpt_icon":0},{"id":"2536682349","title":"MetaVia price target lowered to $3 from $6 at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2536682349","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536682349?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:50","pubTimestamp":1747659011,"startTime":"0","endTime":"0","summary":"Maxim analyst Jason McCarthy lowered the firm’s price target on MetaVia (MTVA) to $3 from $6 and keeps a Buy rating on the shares. The firm cites t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metavia-price-target-lowered-to-3-from-6-at-maxim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metavia-price-target-lowered-to-3-from-6-at-maxim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2536586601","title":"Maxim Group Sticks to Its Buy Rating for MetaVia (MTVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2536586601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536586601?lang=en_us&edition=fundamental","pubTime":"2025-05-17 21:55","pubTimestamp":1747490121,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy maintained a Buy rating on MetaVia (MTVA – Research Report) yesterday. The company’s shares closed yesterday at ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-its-buy-rating-for-metavia-mtva?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-its-buy-rating-for-metavia-mtva?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTVA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"MTVA","fiscalQuarterEnding":"2025/03","expectedEps":-0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.36},{"date":"2025-03-20","symbol":"MTVA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742457600000,"name":null,"time":"Pre-Market","dateTimestamp":1742443200000,"actualEps":null},{"market":"US","date":"2024-11-07","symbol":"MTVA","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-08-14","symbol":"MTVA","fiscalQuarterEnding":"2024/06","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-1.85},{"market":"US","date":"2024-05-09","symbol":"MTVA","fiscalQuarterEnding":"2024/03","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTVA","date":"2025-07-25","current":-0.587857,"percent":0.20625,"low":-0.807761,"twenty":-0.5965,"median":-0.521601,"eighty":-0.450482,"high":-0.203888,"avg":-0.502221,"sd":0.141241,"marketCap":14431313},"quantilePoints":[{"date":"2024-12-06","current":-0.714557,"twenty":-0.800304,"median":-0.792227,"eighty":-0.751814,"marketCap":19816823},{"date":"2024-12-13","current":-0.716111,"twenty":-0.79347,"median":-0.728538,"eighty":-0.7158,"marketCap":19859903},{"date":"2024-12-20","current":-0.546792,"twenty":-0.767348,"median":-0.716111,"eighty":-0.685354,"marketCap":15164177},{"date":"2024-12-27","current":-0.562326,"twenty":-0.746234,"median":-0.70213,"eighty":-0.556112,"marketCap":15594978},{"date":"2025-01-03","current":-0.655529,"twenty":-0.730091,"median":-0.686597,"eighty":-0.553006,"marketCap":18179781},{"date":"2025-01-10","current":-0.661742,"twenty":-0.733198,"median":-0.686597,"eighty":-0.564811,"marketCap":18352101},{"date":"2025-01-17","current":-0.58718,"twenty":-0.720771,"median":-0.663296,"eighty":-0.577238,"marketCap":16284258},{"date":"2025-01-24","current":-0.602714,"twenty":-0.720771,"median":-0.647762,"eighty":-0.584073,"marketCap":16715059},{"date":"2025-01-31","current":-0.584073,"twenty":-0.717664,"median":-0.630675,"eighty":-0.584073,"marketCap":16198098},{"date":"2025-02-07","current":-0.562326,"twenty":-0.716111,"median":-0.615141,"eighty":-0.562326,"marketCap":15594978},{"date":"2025-02-14","current":-0.512617,"twenty":-0.714557,"median":-0.608927,"eighty":-0.546792,"marketCap":14216416},{"date":"2025-02-21","current":-0.509511,"twenty":-0.704615,"median":-0.602714,"eighty":-0.540578,"marketCap":14130256},{"date":"2025-02-28","current":-0.453589,"twenty":-0.699297,"median":-0.58718,"eighty":-0.518583,"marketCap":12579374},{"date":"2025-03-07","current":-0.487763,"twenty":-0.688995,"median":-0.584073,"eighty":-0.503297,"marketCap":13527135},{"date":"2025-03-14","current":-0.467569,"twenty":-0.681626,"median":-0.568539,"eighty":-0.495468,"marketCap":12967095},{"date":"2025-03-21","current":-0.48401,"twenty":-0.667956,"median":-0.562326,"eighty":-0.487763,"marketCap":13354815},{"date":"2025-03-28","current":-0.48933,"twenty":-0.662363,"median":-0.546792,"eighty":-0.487763,"marketCap":13501595},{"date":"2025-04-04","current":-0.47992,"twenty":-0.656772,"median":-0.540578,"eighty":-0.485083,"marketCap":13241949},{"date":"2025-04-11","current":-0.429732,"twenty":-0.643102,"median":-0.539025,"eighty":-0.482756,"marketCap":11857170},{"date":"2025-04-17","current":-0.23033,"twenty":-0.636267,"median":-0.537471,"eighty":-0.476844,"marketCap":6355270},{"date":"2025-04-25","current":-0.266622,"twenty":-0.631917,"median":-0.512617,"eighty":-0.463425,"marketCap":7356638},{"date":"2025-05-02","current":-0.239019,"twenty":-0.626947,"median":-0.506404,"eighty":-0.454331,"marketCap":6595010},{"date":"2025-05-09","current":-0.222708,"twenty":-0.618869,"median":-0.49874,"eighty":-0.452346,"marketCap":6144956},{"date":"2025-05-16","current":-0.238257,"twenty":-0.615141,"median":-0.497083,"eighty":-0.429105,"marketCap":5848960},{"date":"2025-05-23","current":-0.285534,"twenty":-0.611413,"median":-0.49458,"eighty":-0.263184,"marketCap":7009578},{"date":"2025-05-30","current":-0.543676,"twenty":-0.612655,"median":-0.49689,"eighty":-0.271352,"marketCap":13346706},{"date":"2025-06-06","current":-0.549972,"twenty":-0.608927,"median":-0.497673,"eighty":-0.281282,"marketCap":13501264},{"date":"2025-06-13","current":-0.597709,"twenty":-0.608927,"median":-0.503297,"eighty":-0.294785,"marketCap":14673160},{"date":"2025-06-20","current":-0.557862,"twenty":-0.607995,"median":-0.509511,"eighty":-0.332562,"marketCap":13694949},{"date":"2025-06-27","current":-0.542591,"twenty":-0.603956,"median":-0.515396,"eighty":-0.428478,"marketCap":13320078},{"date":"2025-07-03","current":-0.516978,"twenty":-0.602714,"median":-0.515103,"eighty":-0.429732,"marketCap":12691292},{"date":"2025-07-11","current":-0.572913,"twenty":-0.599701,"median":-0.516978,"eighty":-0.432869,"marketCap":14064436},{"date":"2025-07-18","current":-0.535431,"twenty":-0.597709,"median":-0.518414,"eighty":-0.439456,"marketCap":13144307},{"date":"2025-07-25","current":-0.587857,"twenty":-0.5965,"median":-0.521601,"eighty":-0.450482,"marketCap":14431313}],"updateTime":1753520114883}}}